Artiva Biotherapeutics (ARTV) Equity Ratio (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Equity Ratio for 3 consecutive years, with 0.84 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 5.69% to 0.84 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.84 through Dec 2025, down 5.69% year-over-year, with the annual reading at 0.84 for FY2025, 5.69% down from the prior year.
- Equity Ratio for Q4 2025 was 0.84 at Artiva Biotherapeutics, down from 0.87 in the prior quarter.
- The five-year high for Equity Ratio was 0.89 in Q3 2024, with the low at 2.52 in Q2 2024.
- Average Equity Ratio over 3 years is 0.15, with a median of 0.87 recorded in 2025.
- The sharpest move saw Equity Ratio surged 157.78% in 2024, then fell 5.69% in 2025.
- Over 3 years, Equity Ratio stood at 1.54 in 2023, then surged by 157.78% to 0.89 in 2024, then dropped by 5.69% to 0.84 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods came in at 0.84, 0.87, and 0.88 for Q4 2025, Q3 2025, and Q2 2025 respectively.